Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interval Warm-up vs Albuterol for EIB in Asthmatic Children
NCT03586544Phase 4Terminated
- Sponsor
- University of Nevada, Las Vegas
- Start
- Sep 2018
- Primary completion
- Mar 2020
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by University of Nevada, Las Vegas. Primary endpoint: Maximum Percent Change in Forced Expiratory Volume in the First Second. Started Sep 2018; status: terminated.
Beyond the preview
Go deeper on NCT03586544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03586544.